P4HA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.599800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.243200E-01
Normal-vs-Stage2
2.308600E-01
Normal-vs-Stage3
4.222200E-01
Normal-vs-Stage4
1.922000E-01
Stage1-vs-Stage2
2.883600E-01
Stage1-vs-Stage3
7.596000E-01
Stage1-vs-Stage4
1.791240E-01
Stage2-vs-Stage3
5.280600E-01
Stage2-vs-Stage4
5.451600E-01
Stage3-vs-Stage4
3.790600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.713800E-01
Normal-vs-AfricanAmerican
2.328000E-01
Normal-vs-Asian
2.144600E-01
Caucasian-vs-AfricanAmerican
4.879700E-02
Caucasian-vs-Asian
9.741000E-01
AfricanAmerican-vs-Asian
3.298200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.881800E-01
Normal-vs-Female
2.291800E-01
Male-vs-Female
9.765400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.087400E-01
Normal-vs-Age(41-60Yrs)
1.488020E-01
Normal-vs-Age(61-80Yrs)
3.125800E-01
Normal-vs-Age(81-100Yrs)
4.262800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.332400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.073200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.980400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.484100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.141400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.051400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.216800E-01
Normal-vs-Daily Drinker
3.520800E-01
Normal-vs-Weekly Drinker
2.121400E-01
Normal-vs-Occasional Drinker
1.654620E-01
Normal-vs-Social Drinker
2.402200E-01
Non Drinker-vs-Daily Drinker
4.342800E-01
Non Drinker-vs-Weekly Drinker
8.513000E-01
Non Drinker-vs-Occasional Drinker
8.579700E-02
Non Drinker-vs-Social Drinker
4.824800E-01
Daily Drinker-vs-Weekly Drinker
5.447800E-01
Daily Drinker-vs-Occasional Drinker
4.028600E-01
Daily Drinker-vs-Social Drinker
8.814600E-01
Weekly Drinker-vs-Occasional Drinker
1.265360E-01
Weekly Drinker-vs-Social Drinker
6.377200E-01
Occasional Drinker-vs-Social Drinker
3.107800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.627400E-01
Normal-vs-Grade 2
3.446400E-01
Normal-vs-Grade 3
3.979800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.497550E-01
Grade 1-vs-Grade 3
7.747800E-02
Grade 1-vs-Grade 4
7.627400E-01
Grade 2-vs-Grade 3
4.148600E-01
Grade 2-vs-Grade 4
3.446400E-01
Grade 3-vs-Grade 4
3.979800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.026000E-01
Normal-vs-NonDiabetic
2.563400E-01
Diabetic-vs-NonDiabetic
7.612200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.110350E-01
Normal-vs-NoPancreatitis
2.705000E-01
Pancreatitis-vs-NoPancreatitis
7.160800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.329200E-01
Normal-vs-N1
2.262600E-01
N0-vs-N1
6.485700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.879550E-01
Normal-vs-TP53-NonMutant
8.155600E-01
TP53-Mutant-vs-TP53-NonMutant
3.79019999999786E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
